Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti PD-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05425576
What this trial is testing

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Who this might be right for
Malignant Pleural Mesothelioma
Oncotelic Inc. 63
Early research (Phase 1)WithdrawnNCT05717140
What this trial is testing

Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the LungMetastatic Melanoma+2 more
Mayo Clinic
Large-scale testing (Phase 3)UnknownNCT03605706
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT05468177
What this trial is testing

Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer

Who this might be right for
Colonic Neoplasms
Tongji Hospital 66
Large-scale testing (Phase 3)Ended earlyNCT02967692
What this trial is testing

The Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Looking for participantsNCT05978193
What this trial is testing

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04701307
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Who this might be right for
Lung Small Cell CarcinomaNeuroendocrine CarcinomaStage III Lung Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT03776136
What this trial is testing

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Who this might be right for
Advanced Melanoma
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT03134872
What this trial is testing

SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more
Jiangsu HengRui Medicine Co., Ltd. 419
Not applicableStudy completedNCT04627012
What this trial is testing

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases
Sun Yat-sen University 600
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Early research (Phase 1)Active Not RecruitingNCT04658147
What this trial is testing

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Early research (Phase 1)Active Not RecruitingNCT04470024
What this trial is testing

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Who this might be right for
Cancer of the Head and Neck
Providence Health & Services 19
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Testing effectiveness (Phase 2)Ended earlyNCT05581719
What this trial is testing

A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Who this might be right for
Solid TumorPeritoneal MetastasesPeritoneal Cancer
Enlivex Therapeutics RDO Ltd. 14
Testing effectiveness (Phase 2)UnknownNCT06543836
What this trial is testing

CtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Not applicableLooking for participantsNCT05332925
What this trial is testing

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Who this might be right for
Lung CancerNSCLCNSCLC Stage IV
Jun Zhang, MD, PhD 25
Next Page